Study found that patients who received sotrovimab showed an 85 percent reduction in their risk for hospitalization or death versus placebo
FDA Plans to Approve Pfizer Vaccine for Those Aged 12 Years and Older
Pfizer’s trial in adolescents showed its vaccine worked as well in teens as it does in adults
FDA: Multiple Violations Found at Baltimore Plant Making COVID-19 Vaccines
Violations included not properly disinfecting equipment, not following procedures meant to prevent contamination, improperly trained employees
Restrictions on Access to Abortion Pill Will Be Lifted During Pandemic
Decision means that health care providers in some states will be able to prescribe mifepristone via telemedicine and mail the pills to patients
FDA to Decide ‘Quickly’ on Pfizer Request to Approve COVID-19 Vaccine for Children 12 to 15
Currently, the FDA allows the Pfizer vaccine to be given to people 16 years and older
AstraZeneca to Seek FDA Approval of COVID-19 Vaccine Within Weeks
If the two-dose vaccine is approved, it would be the fourth COVID-19 vaccine available in the United States
FDA Warns Consumers to Not Use Ivermectin for COVID-19
Agency has received reports of patients requiring medical support after self-medicating with ivermectin for use in horses
J&J COVID-19 Vaccine Granted Emergency Use Authorization
The single-dose Ad26 vaccine is now the third COVID-19 vaccine to be granted an EUA
FDA Warns Not to Rely on Pulse Oximetry for Diagnosis, Treatment Decisions
Safety communication follows NEJM study showing risk for inaccuracy with use of pulse oximeters in those with dark skin pigmentation
Combination Monoclonal Antibody Treatment Authorized for COVID-19
EUA issued for combination of bamlanivimab and etesevimab in patients with mild-to-moderate COVID-19 at high risk for disease progression